Arda OZTAN, Gülsüm AK, Murat ULUSAN, Semra DEMOKAN

17493

INVESTIGATION OF METHYLATION AND EXPRESSION STATUS OF PAX1 GENE VIA EPIGENOMIC PROFILING IN ORAL MALIGNANT LESIONS

Introduction: Our previously study (TUBITAK-SBAG-114S497) showed hypermethylation of the PAX1 gene in Turkish oral squamous cell carcinoma (OSCC) patients via methylation-array results. In this study, we aimed to validate its potential as an epigenetic biomarker for OSCC by analyzing the methylation status and the changes in methylation-related gene expression of the PAX1 gene in Turkish OSCC patient and healthy groups. Material and Methods: Expression and methylation levels of PAX1 gene were analyzed by Quantitative Real Time-PCR and Quantitative Methylation Specific PCR methods respectively, in tissues and body-fluid samples of 30 OSCC patients and 30 healthy individuals. Results: The methylation rates of the PAX1 gene in matched-normal tissue, tumors, serum and saliva samples of OSCC patients were 50%, 73%, 40%, and 66%, respectively. The methylation rates of the PAX1 gene in normal mucosa, serum and saliva samples of healthy individuals were found to be 6%, 0 and 10%, respectively. In the malignant group, 59% patients in whom methylation was observed in the promoter region of the PAX1 gene in the tumor tissue was found to have decreased expression levels in the tumor tissues compared to the matched-normal tissues. Conclusion: DNA hypermethylation of PAX1 gene may play a role in oral carcinogenesis and may be used as an epigenetic biomarker.

Anahtar Kelimeler:

OSCC, hypermethylation, epigenetic biomarker, PAX1

INVESTIGATION OF METHYLATION AND EXPRESSION STATUS OF PAX1 GENE VIA EPIGENOMIC PROFILING IN ORAL MALIGNANT LESIONS

Introduction: Our previously study (TUBITAK-SBAG-114S497) showed hypermethylation of the PAX1 gene in Turkish oral squamous cell carcinoma (OSCC) patients via methylation-array results. In this study, we aimed to validate its potential as an epigenetic biomarker for OSCC by analyzing the methylation status and the changes in methylation-related gene expression of the PAX1 gene in Turkish OSCC patient and healthy groups. Material and Methods: Expression and methylation levels of PAX1 gene were analyzed by Quantitative Real Time-PCR and Quantitative Methylation Specific PCR methods respectively, in tissues and body-fluid samples of 30 OSCC patients and 30 healthy individuals. Results: The methylation rates of the PAX1 gene in matched-normal tissue, tumors, serum and saliva samples of OSCC patients were 50%, 73%, 40%, and 66%, respectively. The methylation rates of the PAX1 gene in normal mucosa, serum and saliva samples of healthy individuals were found to be 6%, 0 and 10%, respectively. In the malignant group, 59% patients in whom methylation was observed in the promoter region of the PAX1 gene in the tumor tissue was found to have decreased expression levels in the tumor tissues compared to the matched-normal tissues. Conclusion: DNA hypermethylation of PAX1 gene may play a role in oral carcinogenesis and may be used as an epigenetic biomarker.

Keywords:

OSCC, hypermethylation, epigenetic biomarker, PAX1,

___

Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605-44.

Sağlık Bilimlerinde İleri Araştırmalar Dergisi-Cover

Yayın Aralığı: Yılda 3 Sayı
Başlangıç: 2018
Yayıncı: İstanbul Üniversitesi

Arşiv

Sayıdaki Diğer Makaleler

INVESTIGATION OF THE EFFECT PISTACIA VERA FROM DIFFERENT REGIONS ON OXIDATIVE STRESS AND PROLIFERATION IN BREAST CANCER CELL LINE

İpek GÜRKEBABÇI, Basak KOCDOR, Hilal KOÇDOR

EFFECT OF THYMOQUINONE IN COMBINATION WITH NIVOLUMAB ON EXPERIMENTAL RENAL CELL CANCER MODELS

Ahmet DİRİCAN, Safiye AKTAŞ, Tekincan Çağrı AKTAŞ, Aylin EROL, Özde Elif GÖKBAYRAK, Efsun KOLATAN, Efe Özgür SERİNAN, Zekiye ALTUN, Işıl SOMALI, Osman YILMAZ

APPLICATIONS OF TRANSCRIPTOMICS METHODS IN BREAST CANCER

Yesim GOKMEN-POLAR

THE EFFECT OF SILENCING THE Tip60 GENE ON THE RESPONSE TO RADIOTHERAPY IN BREAST CANCER CELLS

Ece MİSER SALİHOĞLU, Bensu KARAHALİL, Sevgi AKAYDIN

ANALYSIS OF TRIBBLES HOMOLOG 3 (TRIB3) EXPRESSION LEVELS IN NEUROBLASTOMA: PRELIMINARY STUDY

Burçin BARAN, Gamze SANLAV, Deniz KIZMAZOĞLU, Selen KUM ÖZŞENGEZER, Safiye AKTAŞ, Zekiye ALTUN, Nur OLGUN

IMPACT OF COMPREHENSIVE GENOMIC PROFILING NGS PANELS IN PRECISION ONCOLOGY: THE CITY OF HOPE CMDL EXPERIENCE

CircRNAs OF SALIVA AS POTENTIAL BIOMARKERS FOR COLORECTAL CANCER DIAGNOSIS

Afet SATTAROVA, Milad ASADİ, Tayfun YOLDAŞ, Osman BOZBIYIK, Ahmad AL-OMAR, Can MUFTUOGLU, Ufuk MERT, Ayşe CANER

EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPY

Saina RAHİMİ, Milad ASADİ, Can MUFTUOGLU, Emin TAVLAYAN, Ozlem OZKAYA AKAGUNDUZ, Ufuk MERT, Ayse CANER

miRNA-REGULATED PATHWAYS OF CD8+T CELLS IN TNBC MOUSE MODEL

Muge OCAL-DEMİRTAS, Doç. Dr. Bala GÜR DEDEOĞLU

NEXT-GENERATION SEQUENCING IN CANCER: GENETIC DIAGNOSIS, RISK PREDICTION AND CLASSIFICATION